Sanjay H. Jayasinghe
Westmead, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
ATAGI targeted review 2025: Immunisation considerations for immunocompromised people in Australia.
Journal: Communicable diseases intelligence (2018)
Published: August 25, 2026
ATAGI Targeted Review 2024: Immunisation strategies for prevention and control of respiratory syncytial virus disease in Australia.
Journal: Communicable diseases intelligence (2018)
Published: May 22, 2026
The Evolving Epidemiology of Invasive Pneumococcal Disease in Australian Children: A Multicentre Retrospective Observational Study.
Journal: Open forum infectious diseases
Published: December 11, 2025
Invasive pneumococcal disease in Australia: 2013 and 2014.
Journal: Communicable diseases intelligence (2018)
Published: October 21, 2025
Prevalence and serotype distribution of nasopharyngeal carriage of Streptococcus pneumoniae in Vietnam: a systematic review and meta-analysis.
Journal: The Lancet regional health. Western Pacific
Published: September 04, 2025
Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE project.
Journal: The Journal of infection
Published: October 11, 2024
ATAGI targeted review 2023: Vaccination for preventing influenza in Australia.
Journal: Communicable diseases intelligence (2018)
Published: July 18, 2024
Trends in Hospitalisations for Vaccine Preventable Respiratory Infections Following Emergency Department Presentations in New South Wales, Australia, 2012-2022.
Journal: Influenza and other respiratory viruses
Published: July 03, 2024
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis.
Journal: The Lancet. Infectious diseases
Published: June 01, 2024
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis.
Journal: The Lancet. Infectious diseases
Published: May 31, 2024
Assessing the Impact of Pneumococcal Conjugate Vaccine Immunization Schedule Change From 3+0 to 2+1 in Australian Children: A Retrospective Observational Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 05, 2024
Last Updated: 09/26/2026